Jamil R. Azzi MD, PhD is an Associate Professor of Medicine at Harvard Medical School. Dr. Azzi is an immunologist who is leading an NIH funded laboratory that focuses on understanding the immune-regulatory arm of the immune system in transplantation and autoimmunity with the goal of developing more targeted and safer therapeutic strategies. Dr. Azzi’s laboratory is also exploring multiple genomics and proteomics approaches to develop diagnostic, prognostic, and predictive biomarkers in kidney transplant recipients and inflammatory kidney diseases. His work led to the development of the ExoTRU test licensed to ThermoFisher. In addition to his busy science career, he never stopped seeing kidney transplant patients at Brigham and Women’s where he is currently the medical director of the kidney and pancreas transplant program and of the vascularized composite allo-transplantation (VCA) program.
Dr. Azzi served the AST in different capacities since 2008; He has been a member of the executive committees of multiple AST Communities of Practice. For one, he was a member and chair of the Trainee and Young Faculty COP and of the Community of Transplant Scientists. Secondly, he was the chair and founder of the “Outstanding Questions in Transplantation” for the Community of Transplant Scientists, which has more than 3,000 AST members. This Community of Practice played a leading role in bringing the transplant community together, to discuss critical unmet needs in transplantation today. Additionally, he was invited by the AST Board of Directors to join the Patient Summit Task Force, which organized the first transplant patient summit in Washington, DC in 2017, in which he represented the basic scientists of the AST. A few other committees that he has served include the Awards and Grants Committee, the AST Educational Committee, the Fellows Symposium committee, the Transplant Community Summit committee, and the Future of Transplantation Organizing Committee. Currently, he is the chair of the AST Scientific Review Committee, and he has also served as chair and reviewer on several abstract review committees, along with being a moderator at scientific sessions for the American Transplant Congress.
Advertisements
